Why the study?
Does a lower oxidative balance score increase the risk of advanced staging and mortality in patients with cardiovascular-kidney-metabolic syndrome?
Does a lower oxidative balance score increase the risk of advanced staging and mortality in patients with cardiovascular-kidney-metabolic syndrome?
Answers are grounded in this paper and cite their sources.
A lower oxidative balance score is associated with advanced cardiovascular-kidney-metabolic syndrome staging and higher mortality risk, suggesting its potential utility as a risk stratification tool.
To evaluate the roles of oxidative balance score (OBS) in staging and mortality risk of cardiovascular-kidney-metabolic syndrome (CKM). Data of this study were from the National Health and Nutrition Examination Survey 1999-2018. We performed cross-sectional analyses using multinomial logistic regression to investigate the relationship between OBS and CKM staging. Cox proportional hazards models were used to assess the impact of OBS on mortality outcomes in CKM patients. Additionally, mediation analyses were performed to explore whether OBS mediated the relationships between specific predictors (Life’s Simple 7 score [LS7], systemic immune-inflammation index [SII], frailty score) and mortality outcomes. Then, machine learning models were developed to classify CKM stages 3/4 and predict all-cause mortality, with SHapley Additive exPlanations values used to interpret the contribution of OBS components. 21,609 participants were included (20,319 CKM, median [IQR] age: 52.0[38.0–65.0]years, 54.3%male, median [IQR] follow-up: 9.4[5.3-14.1]years). Lower OBS quartiles were associated with advanced CKM staging. Moreover, lower OBS quartiles were related to increased mortality risk, compared to Q4 of OBS (all-cause mortality: Q1: HR 1.31, 95%CI 1.18-1.46, Q2: HR 1.27, 95%CI 1.14-1.42, Q3: HR 1.18, 95%CI 1.06-1.32; cardiovascular mortality: Q1: HR 1.44, 95%CI 1.16-1.79, Q2: HR 1.39, 95%CI 1.11-1.74, Q3: HR 1.26, 95%CI 1.01-1.57; non-cardiovascular mortality, Q1: HR 1.27, 95%CI 1.12-1.44, Q2: HR 1.23, 95%CI 1.08-1.40, Q3: HR 1.16, 95% CI 1.02-1.31), with optimal risk stratification threshold for OBS was 22. Additionally, OBS mediated (ranging 4.25%-32.85%) effects of SII, LS7, frailty scores on mortality outcomes. Moreover, light gradient boosting machine achieved the highest performance for predicting advanced CKM staging (area under curve:0.905) and all-cause mortality (area under curve:0.875). Cotinine increased risk, while magnesium, vitamin B6, physical activity were protective. This study highlights OBS as a risk stratification tool for CKM, emphasizing oxidative stress’s role in CKM staging and mortality risk management. • This study first evaluates the role of oxidative balance score (OBS) in staging and mortality risk in cardiovascular-kidney-metabolic syndrome (CKM). • Lower OBS was linked to advanced CKM stages and higher all-cause, cardiovascular, and non-cardiovascular mortality risks. • The optimal OBS cutoff for identifying high-risk CKM patients was 22. • OBS mediated the effects of systemic immune-inflammation index, Life’s Simple 7 score, and frailty score on mortality outcomes. • LightGBM achieved the high performance for advanced CKM staging and all-cause mortality, cotinine was the strongest pro-oxidant risk factor.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: